NeuBase Therapeutics, Inc. (NBSE): Price and Financial Metrics
NBSE Price/Volume Stats
| Current price | $0.38 | 52-week high | $4.80 |
| Prev. close | $0.39 | 52-week low | $0.36 |
| Day low | $0.37 | Volume | 97,700 |
| Day high | $0.39 | Avg. volume | 191,869 |
| 50-day MA | $0.60 | Dividend yield | N/A |
| 200-day MA | $0.76 | Market Cap | 1.42M |
NBSE Stock Price Chart Interactive Chart >
NeuBase Therapeutics, Inc. (NBSE) Company Bio
NeuBase Therapeutics, Inc. produces and distributes pharmaceutical products. The Company offers drugs for the treatment of dominant genetic disorders and oncogenic mutations causing cancers. NeuBase Therapeutics serves patients in the United States.
NBSE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | -42.42% |
| 3-year | -99.42% |
| 5-year | -99.70% |
| YTD | -48.66% |
| 2023 | -80.54% |
| 2022 | -93.23% |
| 2021 | -59.80% |
| 2020 | -2.92% |
| 2019 | 300.00% |
Loading social stream, please wait...